IQ U.S. Mid Cap R&D Leaders ETF (MRND)
| Assets | $4.31M |
| NAV | $21.54 |
| Expense Ratio | 0.16% |
| PE Ratio | 20.47 |
| Shares Out | 200,000 |
| Dividend (ttm) | $0.03 |
| Dividend Yield | 0.14% |
| Ex-Dividend Date | Mar 18, 2022 |
| 1-Year Return | -10.98% |
| Volume | 2 |
| Open | 21.59 |
| Previous Close | 23.09 |
| Day's Range | 22.49 - 23.11 |
| 52-Week Low | 20.35 |
| 52-Week High | 25.97 |
| Beta | -1.37 |
| Holdings | 102 |
| Inception Date | Feb 8, 2022 |
About MRND
The underlying index seeks to provide exposure to innovative companies by investing in the equities of U.S. mid cap companies that have high research and development ("R&D") spending. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. It is non-diversified.
News
9 New ETFs for Investors to Unwrap
The U.S. exchange-traded fund (ETF) industry had quite a year in 2021 – due in part to the 445 new ETFs that launched, 44% more than did in 2020. U.S. ETFs ended the year with record assets of $7.21 tri...
IndexIQ Launches R&D-Focused ETF Trio
New York Life's ETF brand is targeting companies that spend big on research.
IndexIQ Launches Trio of Growth ETFs
IndexIQ has expanded its ETF product lineup with the launch of three new equity-focused strategies. The new trio of funds — the IQ U.S. Large Cap R&D Leaders ETF (LRND), the IQ U.S. Mid Cap R&D Leaders ...
IndexIQ Introduces ETF Suite Focused on Leaders in Research & Development
NEW YORK--(BUSINESS WIRE)--New IndexIQ ETFs are designed to provide exposure to companies positioned for future innovation and expansion through sustained investment in R&D.